Cytosorbents Corporation (CTSO)

Cytosorbents Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Cytosorbents stock have an average target of 4.67, with a low estimate of 1.00 and a high estimate of 10. The average target predicts an increase of 309.65% from the current stock price of 1.14.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.00	$4.67	$3.00	$10
Change	-12.28%	+309.65%	+163.16%	+777.19%

Analyst Ratings

The average analyst rating for Cytosorbents stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $1	Hold	Reiterates	$1	-12.28%	Apr 3, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+777.19%	Apr 1, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+777.19%	Feb 25, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+777.19%	Jan 13, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+777.19%	Jan 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

42.26M

Increased by 18.72%

from 35.59M

Revenue Next Year

50.61M

Increased by 19.75%

from 42.26M

EPS This Year

-0.24

from -0.38

EPS Next Year

-0.12

from -0.24

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	41.00M	43.17M	34.69M	31.08M	35.59M	42.26M	50.61M	66.58M
Revenue Growth	64.35%	5.27%	-19.64%	-10.39%	14.51%	18.72%	19.75%	31.55%
EPS	-0.20	-0.57	-0.75	-0.65	-0.38	-0.24	-0.12	-0.03
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	49.4M	63.5M	82.3M
Avg	42.3M	50.6M	66.6M
Low	36.7M	41.3M	51.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	38.8%	50.3%	62.6%
Avg	18.7%	19.8%	31.6%
Low	3.0%	-2.4%	1.0%

EPS Forecast

EPS	2025	2026	2027
High	-0.22	-0.09	0.06
Avg	-0.24	-0.12	-0.03
Low	-0.25	-0.17	-0.11

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.